Zacks: Brokerages Expect Endo International PLC (NASDAQ:ENDP) to Announce $0.57 Earnings Per Share

Share on StockTwits

Equities research analysts expect Endo International PLC (NASDAQ:ENDP) (TSE:ENL) to report earnings per share (EPS) of $0.57 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Endo International’s earnings. The highest EPS estimate is $0.59 and the lowest is $0.55. Endo International reported earnings of $0.75 per share during the same quarter last year, which would indicate a negative year over year growth rate of 24%. The company is scheduled to report its next earnings results on Thursday, February 27th.

According to Zacks, analysts expect that Endo International will report full-year earnings of $2.20 per share for the current fiscal year, with EPS estimates ranging from $2.09 to $2.23. For the next year, analysts anticipate that the firm will post earnings of $2.32 per share, with EPS estimates ranging from $1.82 to $2.58. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Endo International.

Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.07. The firm had revenue of $729.00 million for the quarter, compared to analyst estimates of $709.01 million. Endo International had a negative return on equity of 99.08% and a negative net margin of 16.89%. The company’s revenue was down 2.1% on a year-over-year basis. During the same quarter last year, the company earned $0.71 EPS.

ENDP has been the subject of a number of analyst reports. BidaskClub raised Endo International from a “sell” rating to a “hold” rating in a research note on Tuesday, December 3rd. ValuEngine cut shares of Endo International from a “hold” rating to a “sell” rating in a research report on Thursday, November 7th. Three investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $7.78.

Shares of ENDP traded down $0.07 during trading hours on Monday, hitting $4.63. 5,266,669 shares of the company were exchanged, compared to its average volume of 7,055,606. Endo International has a fifty-two week low of $1.97 and a fifty-two week high of $12.49. The company has a market cap of $995.55 million, a price-to-earnings ratio of 1.83 and a beta of 1.43. The firm’s fifty day moving average is $4.65 and its 200 day moving average is $3.91.

In other news, Director Roger H. Kimmel sold 25,000 shares of Endo International stock in a transaction on Monday, September 16th. The stock was sold at an average price of $4.09, for a total value of $102,250.00. Following the transaction, the director now owns 123,309 shares in the company, valued at approximately $504,333.81. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.50% of the company’s stock.

Several hedge funds have recently bought and sold shares of ENDP. Paloma Partners Management Co bought a new stake in shares of Endo International during the 2nd quarter valued at approximately $98,000. Meeder Asset Management Inc. lifted its stake in Endo International by 47.1% in the 2nd quarter. Meeder Asset Management Inc. now owns 37,887 shares of the company’s stock valued at $156,000 after purchasing an additional 12,127 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Endo International by 14.5% in the 3rd quarter. Nisa Investment Advisors LLC now owns 50,690 shares of the company’s stock valued at $163,000 after purchasing an additional 6,434 shares during the last quarter. Commonwealth Bank of Australia boosted its position in Endo International by 41.6% in the second quarter. Commonwealth Bank of Australia now owns 66,400 shares of the company’s stock valued at $273,000 after buying an additional 19,500 shares in the last quarter. Finally, Hunter Associates Investment Management LLC boosted its position in Endo International by 37.4% in the second quarter. Hunter Associates Investment Management LLC now owns 94,075 shares of the company’s stock valued at $388,000 after buying an additional 25,625 shares in the last quarter. 97.05% of the stock is owned by hedge funds and other institutional investors.

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Featured Story: Federal Reserve

Get a free copy of the Zacks research report on Endo International (ENDP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Founders Capital Management Sells 500 Shares of Weingarten Realty Investors
Founders Capital Management Sells 500 Shares of Weingarten Realty Investors
Founders Capital Management Has $28,000 Stock Holdings in Genworth Financial Inc
Founders Capital Management Has $28,000 Stock Holdings in Genworth Financial Inc
Comcast Co.  Stake Boosted by 10 15 Associates Inc.
Comcast Co. Stake Boosted by 10 15 Associates Inc.
10 15 Associates Inc. Has $2.27 Million Stake in Air Products & Chemicals, Inc.
10 15 Associates Inc. Has $2.27 Million Stake in Air Products & Chemicals, Inc.
10 15 Associates Inc. Has $2.86 Million Stock Holdings in CVS Health Corp
10 15 Associates Inc. Has $2.86 Million Stock Holdings in CVS Health Corp
10 15 Associates Inc. Grows Stock Holdings in Canadian Pacific Railway Ltd
10 15 Associates Inc. Grows Stock Holdings in Canadian Pacific Railway Ltd


© 2006-2020 Ticker Report